WT1 epitope‑specific IgG and IgM antibodies for immune‑monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine-Reference-Cited by-同舟云学术

WT1 epitope‑specific IgG and IgM antibodies for immune‑monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine

Published:2022-01-03 Issue:2 Volume:23 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Alzaaqi Shouq¹,Naka Norifumi²,Hamada Kenichiro³,Hosen Naoki⁴,Kanegae Mizuki¹,Outani Hidetatsu⁵,Adachi Mayuko¹,Imanishi Rin¹,Morii Eiichi⁶,Iwai Miki¹,Nakata Jun¹,Fujiki Fumihiro⁷,Morimoto Soyoko⁸,Nakajima Hiroko⁷,Nishida Sumiyuki⁹,Tsuboi Akihiro¹⁰,Oka Yoshihiro⁸,Sugiyama Haruo⁷,Oji Yusuke¹

Affiliation:

1. Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Suita, Osaka 565‑0871, Japan

2. Department of Orthopaedic Surgery, Nachikatsuura Town Onsen Hospital, Nachikatsuura, Wakayama 649‑5331, Japan

3. Hamada Orthopaedic Surgery, Kawanishi City, Hyogo 666‑0021, Japan

4. Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka 565‑0871, Japan

5. Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565‑0871, Japan

6. Department of Pathology, Osaka University Graduate School of Medicine, Suita, Osaka 565‑0871, Japan

7. Department of Cancer Immunology, Osaka University Graduate School of Medicine, Suita, Osaka 565‑0871, Japan

8. Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Suita, Osaka 565‑0871, Japan

9. Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka 565‑0871, Japan

10. Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Suita, Osaka 565‑0871, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference61 articles.

1. Sarcomas of soft tissue and bone;Mazanet;Cancer,1991

2. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): A multicentre, two-cohort, single-arm, open-label, phase 2 trial;Tawbi;Lancet Oncol,2017

3. Novel treatment targets in sarcoma: More than just the GIST;Shoushtari;Am Soc Clin Oncol Educ Book,2014

4. Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis;Saerens;Eur J Cancer,2021

5. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma;Keung;BMC Cancer,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances, opportunities and challenges in developing therapeutic cancer vaccines;Critical Reviews in Oncology/Hematology;2024-01

2. Enzyme-Linked Immunosorbent Assay for Antibodies Against the Tumor-Associated Antigen-Derived Cytotoxic T-Lymphocyte Epitope;Methods in Molecular Biology;2024

3. Healthy Young Adults have Cellular and Humoral Immune Responses to Multiple Tumor-Associated Antigens;J BIOL REG HOMEOS AG;2023

4. WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1;Cancers;2023-01-06

5. Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells;Methods in Cell Biology;2023